Description |
EPH receptor B4 |
elastin microfibril interfacer 1 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Dasatinib
- N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine
- N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE
- N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE
- 3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide
- N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine
- N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE
- N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE
- 3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE
- Tesevatinib
- Fostamatinib
|
|
Diseases |
|
|
GWAS |
|
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cortical surface area (min-P) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
|
Interacting Genes |
9 interacting genes:
APP
CLDN3
DNAJB6
EFNB2
EMILIN1
FBXO7
GRIN1
MAP3K4
SDC3
|
30 interacting genes:
ABI3
BEX3
BEX5
BFSP1
CDCA8
CENPQ
COG7
DYNC1I1
EMILIN2
EPHB4
FBXO28
GNG13
IFT20
LAIR2
LRRIQ1
MIA2
MTMR9
NECAB2
NMI
PLAC9
PRKAA2
RABGEF1
RIBC1
SNAPC5
TAB2
TAX1BP1
TSNAX
YJU2
ZC2HC1C
ZNF655
|
Entrez ID |
2050 |
11117 |
HPRD ID |
02481 |
00563 |
Ensembl ID |
ENSG00000196411
|
ENSG00000138080
|
Uniprot IDs |
P54760
Q541P7
Q96L35
|
Q9Y6C2
|
PDB IDs |
2BBA
2E7H
2HLE
2QKQ
2VWU
2VWV
2VWW
2VWX
2VWY
2VWZ
2VX0
2VX1
2X9F
2XVD
2YN8
3ZEW
4AW5
4BB4
6FNI
6FNJ
6FNK
6FNL
6FNM
|
2KA3
2OII
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|